Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Mar;63(3):279-281.
doi: 10.1002/mus.27109. Epub 2020 Nov 23.

Combination molecular therapies for spinal muscular atrophy: How much is enough?

Affiliations
Editorial

Combination molecular therapies for spinal muscular atrophy: How much is enough?

Katherine D Mathews et al. Muscle Nerve. 2021 Mar.
No abstract available

PubMed Disclaimer

Comment on

References

REFERENCES

    1. Harada Y, Rao VK, Arya K, et al. Combination molecular therapies for type 1 spinal muscular atrophy. Muscle Nerve. 2020;62(4):550-554. https://doi.org/10.1002/mus.27034. Epub 2020 Aug 10. PMID: 32710634.
    1. Lee BH, Collins E, Lewis L, et al. Combination therapy with nusinersen and AVXS-101 in SMA type 1. Neurology. 2019;93(14):640-641. https://doi.org/10.1212/WNL.0000000000008207. Epub 2019 Sep 5. PMID: 31488615.
    1. Mercuri E, Lucibello S, Perulli M, et al. Longitudinal natural history of type I spinal muscular atrophy: a critical review. Orphanet J Rare Dis. 2020;15(1):84. https://doi.org/10.1186/s13023-020-01356-1. PMID: 32248834; PMCID: PMC7132885.
    1. Finkel RS, Mercuri E, Darras BT, et al. Nusinersen versus sham control in infantile-onset spinal muscular atrophy. N Engl J Med. 2017;377(18):1723-1732. https://doi.org/10.1056/NEJMoa1702752. PMID: 29091570.
    1. Waldrop MA, Karingada C, Storey MA, et al. Gene therapy for spinal muscular atrophy: safety and early outcomes. Pediatrics. 2020;146(3):e20200729. https://doi.org/10.1542/peds.2020-0729. PMID: 32843442.

MeSH terms

LinkOut - more resources